BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2649442)

  • 1. Immunophenotypic characterization of follicle-center-cell-derived non-Hodgkin's lymphomas.
    Sakthivel R; Christensson B; Ehlin-Henriksson B; Klein G
    Int J Cancer; 1989 Apr; 43(4):624-30. PubMed ID: 2649442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies. Follicular and diffuse lymphomas of small-cleaved-cell type are related but distinct entities.
    Harris NL; Nadler LM; Bhan AK
    Am J Pathol; 1984 Nov; 117(2):262-72. PubMed ID: 6437232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common acute lymphoblastic leukemia-associated antigen (CALLA)-positive B cell lymphoma.
    Abe M; Nozawa Y; Wachi E; Wakasa H
    Acta Pathol Jpn; 1989 Aug; 39(8):503-8. PubMed ID: 2530751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Tac antigen in B cell lymphomas.
    Laurent G; Al Saati T; Olive D; Laurent JC; Poncelet P; Delsol G
    Clin Exp Immunol; 1986 Aug; 65(2):354-62. PubMed ID: 3024885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
    Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
    Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of a normal B cell subset with a Burkitt-like phenotype and transformation in vitro with Epstein-Barr virus.
    Gregory CD; Edwards CF; Milner A; Wiels J; Lipinski M; Rowe M; Tursz T; Rickinson AB
    Int J Cancer; 1988 Aug; 42(2):213-20. PubMed ID: 2841246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunologic phenotypes of germinal center cell tumors].
    Radaszkiewicz T; Majdic O; Hanak H; Knapp W
    Wien Klin Wochenschr; 1985 Feb; 97(3):126-30. PubMed ID: 2984848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the Leu-8 antigen by B-cell lymphomas.
    Michie SA; Garcia CF; Strickler JG; Dailey MO; Rouse RV; Warnke RA
    Am J Clin Pathol; 1987 Oct; 88(4):486-90. PubMed ID: 3310610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a cell surface molecule expressed on B-lymphocytes and Hodgkin's cells.
    Imam A; Stathopoulos E; Holland SL; Epstein AL; Taylor CR
    Cancer Res; 1990 Mar; 50(5):1650-7. PubMed ID: 1689214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies of immunologic markers in malignant lymphomas: diagnostic and prognostic relevance].
    Huber H; Thaler J; Greil R; Gattringer C; Radaszkiewicz T
    Onkologie; 1986 Apr; 9(2):108-13. PubMed ID: 3520418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the BLA antigen, defined by the monoclonal 38.13 antibody, on Burkitt lymphoma lines, lymphoblastoid cell lines, their hybrids and other B-cell lymphomas and leukemias.
    Klein G; Manneborg-Sandlund A; Ehlin-Henriksson B; Godal T; Wiels J; Tursz T
    Int J Cancer; 1983 May; 31(5):535-42. PubMed ID: 6303966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mantle-zone lymphoma. A pattern produced by lymphomas of more than one cell type.
    Harris NL; Bhan AK
    Am J Surg Pathol; 1985 Dec; 9(12):872-82. PubMed ID: 2933967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Hodgkin's lymphomas of primary follicle/mantle zone origin.
    Weisenburger DD
    Leukemia; 1991; 5 Suppl 1():26-9. PubMed ID: 1716336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
    Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
    Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotypic analysis of extranodal non-Hodgkin's lymphomas in the oral cavity.
    Takahashi H; Fujita S; Okabe H; Tsuda N; Tezuka F
    Pathol Res Pract; 1993 Apr; 189(3):300-11. PubMed ID: 8332573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage.
    Ritz J; Nadler LM; Bhan AK; Notis-McConarty J; Pesando JM; Schlossman SF
    Blood; 1981 Sep; 58(3):648-52. PubMed ID: 6973348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical determination of CD23 expression in Hodgkin's disease using paraffin sections.
    Rowlands DC; Hansel TT; Crocker J
    J Pathol; 1990 Mar; 160(3):239-43. PubMed ID: 2139890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of malignant and non-neoplastic cell phenotypes in highly malignant non-Hodgkin lymphomas.
    Porwit-Ksiazek A; Christensson B; Lindemalm C; Mellstedt H; Tribukait B; Biberfeld G; Biberfeld P
    Int J Cancer; 1983 Dec; 32(6):667-74. PubMed ID: 6317576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.